FR2501M - Le succinate de di-p.acétaminophénol comme antirhumatismal analgésique antipyrétique et les compositions pharmaceutiques pour son administration.
- Google Patents
Le succinate de di-p.acétaminophénol comme antirhumatismal analgésique antipyrétique et les compositions pharmaceutiques pour son administration.
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
RECH S PHARMACOTECHNIQUES SOC
Original Assignee
RECH S PHARMACOTECHNIQUES SOC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by RECH S PHARMACOTECHNIQUES SOCfiledCriticalRECH S PHARMACOTECHNIQUES SOC
Priority to FR918968ApriorityCriticalpatent/FR2501M/fr
Application grantedgrantedCritical
Publication of FR2501MpublicationCriticalpatent/FR2501M/fr
C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
C07C233/16—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
Landscapes
Chemical & Material Sciences
(AREA)
Organic Chemistry
(AREA)
FR918968A1962-12-181962-12-18Le succinate de di-p.acétaminophénol comme antirhumatismal analgésique antipyrétique et les compositions pharmaceutiques pour son administration.
ExpiredFR2501M
(fr)
Le théophylline acétate de phényl-1-amino-2 propane comme stimulant du systeme nerveux central et les compositions pharmaceutiques pour son administration.
Le nicotinate de 2-méthyl, 2-propylpropane diol-1,3 comme nouveau médicament des douleurs musculaires, des affections artérielles et veineuses et les compositions pharmaceutiques pour son utilisation.